Medical network - on March 7, according to incomplete statistics, as of March 19 points, 3 medicine plate with a total of 14 companies released 2016 annual report results. Harbin pharmaceutical shares revenue in the first, up to 14.127 billion yuan, is also the only company revenue super billions. In addition, there are four companies, more than 2 billion yuan revenue respectively with hall (6.249 billion), China pharmaceutical industry (3.018 billion), and daughter pharmaceutical (2.865 billion), and tomson times health (2.309 billion).
Harbin pharmaceutical shares: revenue of 14.127 billion yuan
On March 3, Harbin pharmaceutical co released 2016 annual report. Company business income is 14.127 billion yuan last year, fell 10.91% year on year; Net profit attributable to shareholders of listed companies of 788 million yuan, up 35.85% from a year earlier. Basic earnings per share 0.32 yuan, up 39.13% from a year earlier.
With hall: revenue of 6.249 billion yuan
On February 28, a heart released 2016 annual report. The company's revenues last year 6.249 billion yuan, up 17.44%; Net profit attributable to shareholders of listed companies of 353 million yuan, up 2.06% from a year earlier. Basic earnings per share 0.68 yuan, up 2.06% from a year earlier.
En pharmaceutical: revenue of 3.018 billion yuan
On February 28th, China pharmaceutical released 2016 annual report. The company's revenues last year 3.018 billion yuan, up 9.08%; Net profit attributable to shareholders of listed companies of 310 million yuan, up 19.89% from a year earlier. Basic earnings per share 0.49 yuan, up 19.90% from a year earlier.
Daughter pharmaceutical industry: revenue of 2.865 billion yuan
On February 28, daughter pharmaceutical released 2016 annual report. The company's revenues last year 2.865 billion yuan, up 17.09%; Net profit attributable to shareholders of listed companies of 149 million yuan, up 60.75% from a year earlier. Basic earnings per share 0.43 yuan, up 47.25% from a year earlier.
Tomson times health: revenue of 2.309 billion yuan
On February 28, tomson times health released 2016 annual report. The company's revenues last year 2.309 billion yuan, up 1.90%; Net profit attributable to shareholders of listed companies of 535 million yuan, fell 15.78% year on year; Basic earnings per share 0.37 yuan, down 15.91% year-on-year.
LanFan medical: revenue of 1.289 billion yuan
On February 28, LanFan medical released 2016 annual report. Company business income is 1.289 billion yuan last year, fell 14.59% year on year; Net profit attributable to shareholders of listed companies of 181 million yuan, up 6.38% from a year earlier. Basic earnings per share 0.37 yuan, up 5.71% from a year earlier
Ann figure creature: revenue of 980 million yuan
On March 3, antu biological released 2016 annual report. The company's revenues last year 980 million yuan, up 36.81%; Net profit attributable to shareholders of listed companies of 350 million yuan, up 25.80% from a year earlier. Basic earnings per share 0.89 yuan, up 20.27% from a year earlier.
Essence pharmaceutical: revenue of 881 million yuan
On February 9th, essence pharmaceutical released 2016 annual report. The company's revenues last year 881 million yuan, up 12.96%; Net profit attributable to shareholders of listed companies of 165 million yuan, up 111.36% from a year earlier. Basic earnings per share 0.39 yuan, up 97.44% from a year earlier.
Happy heart health: revenue of 771 million yuan
On March 3, heart health released 2016 annual report. The company's revenues last year 771 million yuan, up 22.52%; Net profit attributable to shareholders of listed companies of 80.5207 million yuan, up 60.44% from a year earlier. Basic earnings per share 1.77 yuan, up 55.26% from a year earlier.
Wide pharmaceutical: a revenue of 715 million yuan
On February 28, wide pharmaceutical released 2016 annual report. The company's revenues last year 715 million yuan, up 27.55%; Net profit attributable to shareholders of listed companies of 142 million yuan, up 577.96% from a year earlier. Basic earnings per share 0.56 yuan, up 579.52% from a year earlier.
WoHua medicine: revenue of 563 million yuan
On Jan. 25, WoHua medicine released 2016 annual report. The company's revenues last year 563 million yuan, up 20.03%; Net profit attributable to shareholders of listed companies of 48.8094 million yuan, fell 31.61% year on year; Basic earnings per share 0.14 yuan, down 30.00% year-on-year.
Hokuriku pharmaceutical: revenue of 499 million yuan
On February 28, hokuriku pharmaceutical released 2016 annual report. The company's revenues last year 499 million yuan, up 1.51%; Net profit attributable to shareholders of listed companies of 16.3795 million yuan, fell 49.72% year on year; Basic earnings per share 0.05 yuan, down 54.55% year-on-year.
Sanxin medical: revenue of 318 million yuan
On February 25, sanxin medical released 2016 annual report. The company's revenues last year 318 million yuan, up 1.90%; Net profit attributable to shareholders of listed companies of 36.614 million yuan, fell 29.42% year on year; Basic earnings per share 0.23 yuan, down 32.35% year-on-year.
Crown exposure creature: revenue of 313 million yuan
On Feb. 27, crown exposure biological released 2016 annual report. The company's revenues last year 313 million yuan, up 38.30%; Net profit attributable to shareholders of listed companies of 65.3711 million yuan, up 3.16% from a year earlier. Basic earnings per share 0.26 yuan, up 0.00% from a year earlier. |
